U.S. health officials report that seasonal influenza activity has started noticeably earlier than usual, pushing mid-October hospital admissions to their highest level for this point in the season since the 2010–2011 period. Experts attribute the early surge primarily to circulating H1N1 viruses.
CDC Surveillance Data Shows Early-Season Flu Spike and Rising Hospitalizations
The Centers for Disease Control and Prevention reported that 4,811 laboratory-confirmed flu hospital admissions were recorded nationwide during the week ending October 17, 2026. By the following week ending October 24, admissions jumped 27% to 6,100 lab-confirmed flu admissions across U.S. hospitals.
Positive influenza test results and emergency department visits have climbed concurrently in recent weeks. Public health laboratories tracking specimens found that nearly all subtyped influenza A viruses were H1N1, overwhelming other circulating strains during the early weeks of the season.
Nearly 5,000 lab-confirmed influenza hospitalizations were reported nationwide during the week ending October 17, according to the Centers for Disease Control and Prevention. Anna Durbin, director of the Johns Hopkins Center for Immunization Research, noted during a media briefing that this is the highest early-season hospital rate for mid-October since the 2010-11 flu season. Separate weekly data from the Centers for Disease Control and Prevention’s FluView report for week 41 showed that approximately 5.7% of clinical lab tests were positive in the week ending October 17. By the week ending October 24, public health laboratories reported 466 influenza viruses, of which 456 were influenza A and 10 were influenza B. Among subtyped influenza A viruses during that same week, 98.9% were influenza A(H1N1)pdm09 and 1.1% were A(H3N2). The Centers for Disease Control and Prevention also received its first report of a child dying from the flu during the 2026-27 season, with the death occurring in the week ending October 10 and linked to the H1N1 strain. The agency counted one more pediatric death from the previous 2025-26 season involving an influenza B case, bringing that prior season's total to 199 children. Across the country, the percentage of visits for respiratory illness increased in the 0-4 years, 5-24 years, 25-49 years, and 50-64 years age groups.
H1N1 Dominates Circulation with Genetic Changes Evolving from Past Strains
The dominant virus driving the surge is a descendant of the H1N1 strain that caused the 2009 swine flu pandemic. While the virus has undergone genetic changes over time, federal health officials state it is not a newly emerged strain. Laboratory surveillance showed that the vast majority of analyzed influenza A samples were H1N1, confirming its overwhelming dominance. Experts note that the agency is observing more genetic diversity among co-circulating A(H1N1)pdm09 viruses than previously recorded. In regional hot spots such as Florida, data from the Walgreens Flu Index showed a high flu score of 4.32 compared to the national average of 2.31 as of October 19, with Broward and Palm Beach counties experiencing higher case counts than the prior week. Meanwhile, international comparisons noted differing timelines, such as Greece entering its flu season approximately 15 days earlier than usual.
It doesn’t necessarily yet mean that this is going to be a particularly severe flu season, but it’s not a good thing necessarily to have serious infections requiring
Dr. Steve Threlkeld, an infectious disease specialist at Baptist Memorial Hospital
Despite the early momentum and genetic shifts, infectious disease specialists emphasize that an unusually fast start does not automatically signal an overall more severe winter peak.
Health Officials Urge Immediate Vaccinations and Joint Respiratory Protection
With case counts rising from regional hot spots in the South and West up to Maryland and Florida, medical professionals are pressing Americans to secure their annual shots without delay. Because antibody development requires approximately two weeks, experts frame the current window as a vital preventative measure before widespread community transmission sets in.
Andrew Pekosz, co-director of the Johns Hopkins Center of Excellence in Influenza Research and Response, emphasized that vaccinations are best taken before the influenza season fully starts because the body requires two weeks to develop antibodies against an invading virus. Preliminary estimates from the Centers for Disease Control and Prevention found that up to 81,000 U.S. residents died of flu-related illness between October 1, 2025, and May 23, 2026. Vaccine options available to the public include traditional shots as well as an mRNA vaccine option.
It’s an early start to the season, and, when it comes to the primary value of the vaccine, it is in prevention of severe disease including hospitalization. It’s too early to know the trajectory of the season, but people should get vaccinated ASAP.
Dr. Amesh A. Adalja, a senior scholar at Johns Hopkins Center for Health Security
In addition to traditional annual influenza shots, health agencies remind eligible individuals that they can simultaneously receive updated COVID-19 and respiratory syncytial virus vaccines. Experts also recommend checking which local pharmacies stock prescription antiviral drugs and emphasize that treatments like antivirals work best when started relatively soon after symptoms appear, particularly for individuals in high-risk groups such as young children, older adults, pregnant people, and those with weakened immune systems.
Readers wishing to evaluate their personal risk or determine appropriate vaccination schedules should consult qualified healthcare professionals, as individual medical advice cannot be provided based on general surveillance data.
